Condition: Hemophilia A · Sponsor: Hoffmann-La Roche
The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of NXT007 prophylaxis compared with emicizumab prophylaxis in people age 12 years and older with severe or moderate congenital hemophilia A without factor VIII (FVIII) inhibitors or with hemophilia A of any severity (severe, moderate, and mild) with FVIII inhibitors.
This description comes directly from the study's public registry record.
Reference Study ID Number: BO45887 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Center for Inherited Blood Disorders | Orange, California, United States | Recruiting |
| Innovative Hematology, Inc. | Indianapolis, Indiana, United States | Recruiting |
| University Of Iowa Hospitals And Clinics | Iowa City, Iowa, United States | Recruiting |
| Washington Center for Bleeding Disorders | Seattle, Washington, United States | Recruiting |
| The Chaim Sheba Medical Center - PPDS | Ramat Gan, Central District, Israel | Recruiting |
| Nagoya University Hospital | Nagoya, Aiti, Japan | Recruiting |
| Gunma University Hospital | Maebashi, Gunma, Japan | Recruiting |
| Nara Medical University Hospital | Kashihara-shi, Nara, Japan | Recruiting |
| Ogikubo Hospital | Suginami-Ku, Tokyo, Japan | Recruiting |
| Hospital Universitario La Paz - PPDS | Madrid, Spain | Recruiting |
| Hospital Regional Universitario de Malaga ? Hospital General | Málaga, Spain | Recruiting |
| Hospital Universitari i Politecnic La Fe de Valencia | Valencia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07416604